Recent learnings from the manufacturer experience
This paper explores what needs to happen in practical terms to optimise patient access to ATMPs in Europe using innovative contracting. It reflects the experience of members of the Alliance for Regenerative Medicine (ARM) in negotiating and implementing these schemes with national payers and provides learnings for the future.
